Project Grant HT94252310595
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30,...
The U.S. Department of Defense's Defense Health Agency awarded a $250,000 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "EPSTEIN-BARR VIRUS IN PATIENTS WITH NEW-ONSET MULTIPLE SCLEROSIS". The project will run from July 1, 2024 to June 30, 2026. As a prime grantee, Yale University will lead this scientific research effort to advance knowledge about the relationship between Epstein-Barr virus and the...
This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
The U.S. Defense Health Agency awarded a $999,006 Project Grant to The Wistar Institute of Anatomy and Biology in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will fund research on Epstein-Barr virus-driven B-cell inflammation and central nervous system trafficking in multiple sclerosis. The Wistar Institute has previously served as a subcontractor on federal grants, providing...
This $4,232,760.00 Project Grant, awarded on June 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members and the broader public. The Leland Stanford Junior University, a private research institution, will conduct innovative scientific investigations focused on advancing cure rates for infantile acute lymphoblastic leukemia. The research aims to...
This $926,400 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant will fund a 3-year research project to conduct an "Integrated Immunophenotypic Transcriptomic and Epigenomic Characterization of Uterine Mesenchymal Neoplasms with Expert Pathologist Panel Review". The objectives are to advance scientific understanding and develop new treatments for these...
This federal Project Grant award of $1,527,730.00, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a longitudinal study among African Americans to determine whether Epstein-Barr virus (EBV)-induced molecular mimicry is a likely cause of multiple sclerosis (MS). The study will leverage pre-diagnostic serum samples and clinical data from over 10 million individuals in the U.S....
This Project Grant award of $999,996.00 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting research at the University of Illinois to investigate the mechanism governing the association between viral respiratory infection relapse and disease progression in persons with multiple sclerosis (MS). The research aims to transform health care for service members and the American public through innovative and impactful research, as...
This federal Project Grant award, valued at $993,283.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports biomedical research focused on advancing understanding of multiple sclerosis progression, to be conducted by the University of California, San Francisco (UCSF) over a period from September 1, 2025 to August 31, 2027. The research aims to identify proteomic determinants and components that drive the...
The Defense Health Agency awarded a $131,655 Project Grant to The Leland Stanford Junior University (Stanford University) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from September 1, 2024 to August 31, 2025, will fund research to identify painful schwannomas (nerve sheath tumors) using a Sigma-1 receptor radioligand and PET/MRI imaging techniques. This research aims to advance the understanding and treatment of...